Oncoclínicas do Brasil Serviços Médicos (ONCO3) reported this Tuesday, July 14, 2026, that on July 13, 2026 it filed for out-of-court reorganization in order to create a stable legal environment to negotiate the restructuring and rescheduling of unsecured financial debt in the approximate amount of R$ 5.1 billion, in addition to other intercompany credits, referred to as Covered Credits.
On the same date as the announcement, the company already had the express adherence to the plan by creditors holding approximately 37% of the Covered Credits, a percentage sufficient to file for out-of-court reorganization. The company has a period of 90 days from the processing of the request to reach the minimum percentage required for court approval of the plan, which will bind 100% of the Covered Credits to the new payment terms.
The reorganization plan may involve, though not necessarily, a capital injection into Oncoclínicas by its shareholders, the conversion of part of the credits into equity interest, the substitution of part of the credits with new debt, and the extension of the amortization schedule of the Covered Credits.
Oncoclínicas stressed that the out-of-court reorganization will not cover current operating obligations with customers, suppliers and other business partners, which will continue to be paid normally on their respective due dates. According to the company, operations continue to be conducted normally in serving customers, suppliers and employees.
As part of the financial restructuring measures, its subsidiary Centro Paulista de Oncologia S.A. terminated an atypical lease agreement under the built-to-suit modality related to a property on Avenida Angélica, in São Paulo, generating an estimated penalty of R$ 76 million, which is included in the list of Covered Credits. Meanwhile, subsidiary Centro Brasileiro de Radioterapia Oncologia e Mastologia – CEBROM Ltda. terminated an atypical built-to-suit lease agreement referring to a planned hospital in Goiânia, whose penalty is being assessed and is still uncertain and unliquidated. The out-of-court reorganization request was unanimously approved by the board of directors and will be submitted for ratification at an extraordinary shareholders’ meeting.
